Amyotrophic Lateral Sclerosis News and Research

RSS

Researchers have discovered a key regulatory molecule for Huntington's disease

Researchers have discovered a key regulatory molecule whose overactivation by the abnormal protein produced in Huntington's disease (HD) causes the central pathologies of the disease.

6 Jul 2005

Columbia University launches multi-year campaign to support stem cell researc

Columbia University Medical Center (CUMC) has announced that it is halfway toward realizing the first phase of a multi-year campaign to build upon the university’s groundbreaking stem cell research and lead the effort to fully realize the therapeutic potential of stem cells.

16 Jun 2005

Diagnostic test for Lou Gehrig's disease

Bowser is director of the ALS Tissue Bank and an Associate Professor of Pathology at the University of Pittsburgh School of Medicine who is using a key piece of biomarker discovery equipment known as SELDI to find new ways to identify and eventually treat Amyotrophic Lateral Sclerosis (ALS), a neurodegenerative disease.

1 Jun 2005

High-dose Tamoxifen may prolong survival in amyotrophic lateral sclerosis (ALS)

Neurologist Benjamin Brooks, who directs the MDA ALS Center at the University of Wisconsin-Madison, presented results of a trial of tamoxifen, a drug approved for the treatment of breast cancer, at a meeting of the American Academy of Neurology in April. The trial was supported in part by MDA.

23 May 2005

Antibiotic minocycline might help alleviate HIV's negative effects on the brain and central nervous system

By studying animals, Johns Hopkins researchers have discovered that the antibiotic minocycline might help alleviate HIV's negative effects on the brain and central nervous system, problems that can develop even though antiretroviral therapy controls the virus elsewhere in the body.

1 May 2005

Researchers insert engineered human stem cells into the spinal cords of ALS-afflicted rats

Unveiling a delivery method that may one day help surgeons treat the deadly neurodegenerative disease amyotrophic lateral sclerosis (ALS), researchers at the University of Wisconsin-Madison have inserted engineered human stem cells into the spinal cords of ALS-afflicted rats.

19 Apr 2005

Researchers have identified the proteins that allow specific brain cells to "change channels"

Johns Hopkins researchers have identified the proteins that allow specific brain cells to "change channels," a rare ability that tweaks what can come into the cell. The findings, described in the March 24 issue of Neuron, might let researchers harness the process, perhaps one day using it to protect cells that die in Lou Gehrig's disease.

28 Mar 2005

Gene therapy helps Lou Gehrig's disease

The most common form of motor neurone disease, called amyotrophic lateral sclerosis (ALS) or Lou Gehrig's disease, is caused when neurones in the spinal cord die, leading to muscle wasting and total paralysis.

14 Mar 2005

Finding points towards the possibility of retrovirus involvement in ALS (amyotrophic lateral sclerosis)

A significant proportion of patients suffering from ALS (amyotrophic lateral sclerosis), also known as Lou Gehrig's disease or motor neuron disease, have a marker of retrovirus activity in their blood, reports the February 8 issue of the medical journal Neurology.

7 Feb 2005

Scientists have coaxed human embryonic stem cells to become spinal motor neurons

After years of trial and error, scientists have coaxed human embryonic stem cells to become spinal motor neurons, critical nervous system pathways that relay messages from the brain to the rest of the body.

30 Jan 2005

Antioxidants do not prolong the survival of patients with amyotrophic lateral sclerosis, or Lou Gehrig’s disease

A review of recent studies suggests that antioxidant supplements, including vitamin E and selenium, do not prolong the survival of patients with amyotrophic lateral sclerosis, or Lou Gehrig’s disease.

24 Jan 2005

Antibiotics protect nerves in mice by turning on genes

A family of antibiotics that includes penicillin may help prevent nerve damage and death in a wide variety of neurological diseases, including Lou Gehrig's disease, dementia, stroke, and epilepsy, Johns Hopkins researchers have found.

6 Jan 2005

Vitamin E supplements may reduce the risk for death from amyotrophic lateral sclerosis (ALS)

Researchers from the Harvard School of Public Health and the American Cancer Society have found that regular use of vitamin E supplements may reduce the risk for death from amyotrophic lateral sclerosis (ALS) also known as Lou Gehrig’s Disease.

21 Dec 2004

Important genetic risk factor for amyotrophic lateral sclerosis

Two Hershey, Pa., researchers were part of a team that has uncovered what may be an important genetic risk factor for amyotrophic lateral sclerosis (ALS).

6 Dec 2004

Next-generation therapeutics with the potential to successfully treat Lou Gehrig's disease

The hopes of many that ALS (commonly referred to as Lou Gehrig's disease) will one day be a disease of the past, studied in medical textbooks, conquered by the dedication of those who have worked tirelessly to eradicate it might be realized in our lifetime.

6 Dec 2004

Amyotrophic Lateral Sclerosis News and Research

Researchers have discovered a key regulatory molecule for Huntington's disease

Columbia University launches multi-year campaign to support stem cell researc

Diagnostic test for Lou Gehrig's disease

High-dose Tamoxifen may prolong survival in amyotrophic lateral sclerosis (ALS)

Antibiotic minocycline might help alleviate HIV's negative effects on the brain and central nervous system

Researchers insert engineered human stem cells into the spinal cords of ALS-afflicted rats

Researchers have identified the proteins that allow specific brain cells to "change channels"

Gene therapy helps Lou Gehrig's disease

Finding points towards the possibility of retrovirus involvement in ALS (amyotrophic lateral sclerosis)

Scientists have coaxed human embryonic stem cells to become spinal motor neurons

Antioxidants do not prolong the survival of patients with amyotrophic lateral sclerosis, or Lou Gehrig’s disease

Antibiotics protect nerves in mice by turning on genes

Vitamin E supplements may reduce the risk for death from amyotrophic lateral sclerosis (ALS)

Important genetic risk factor for amyotrophic lateral sclerosis

Next-generation therapeutics with the potential to successfully treat Lou Gehrig's disease

New possibilities for the use of VEGF in the treatment of Amyotrophic Lateral Sclerosis

Researchers find mutations in a multifunctional protein cause Parkinsonism

Marijuana-like compounds may aid Parkinson's disease, pain and obesity

Human primitive spinal cord cells may delay symptoms and paralysis associated with Lou Gehrig's disease

Robotic microscope shows how mutant Huntington's disease protein affects neurons

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News